An intraocular lens implant is an artificial replacement for the lens of individual person’s eye. It is part of the surgery to fix cataracts. Each eye has a lens, a window made of clear protein, and water that sits behind the pupil. The lens focuses light onto the retina, which sends it to your brain. Ocular implants are type of craniofacial prosthesis that replace an absent natural eye, following an enucleation, evisceration, or orbital exenteration. There are different types of ocular implants ranging from shape such as spherical and oval, stock, and custom. The basic simplification of implants can be to divide them into two main groups: non-integrated (non-porous) and integrated (porous). Ocular implant help to improve the appearance of people with defective eye or with lost eye. Ocular implants are also called as glass eye or artificial eye. Cataracts are a leading cause of blindness, especially in older people. But they can be corrected through surgery a procedure that is done more than 2 million times a year in the U.S. An intraocular lens implant, or IOL, is made of a clear plastic, and it is about a third the size of a dime. There are several different types:
- Monofocal IOL: This is the most common. Unlike a person’s natural lens, which can stretch or bend to help your eye focus, this implant stays focused at one fixed distance. If a person focuses at a distance.
- Multifocal implant: Like glasses with bifocal or progressive lenses, this lens has areas that help a person see things at different distances. It could take several months for a person’s brain to adapt so that a person’s vision seems natural. It can sometimes cause more halos or glare around lights than a monofocal lens.
- Accommodating IOL: This flexible option acts more like humans natural lens and focuses at more than one distance. It makes an individual less likely to need reading glasses.
- Toric IOL: The person will get this if person have astigmatism, or a cornea that's more football-shaped than round. This can make vision blurry all over, not just close up or far away. This lens lessens astigmatism so person won't need glasses to correct it after any individual person surgery.
Market Dynamics
Increasing product launches of different types of ocular implants that are widely used in ophthalmic surgery to correct ophthalmic deformities are expected to drive the global ocular implant market growth. For instance, in February 2019, EyePoint Pharmaceuticals, Inc., Pharmaceutical company launched its YUTIQ in the U.S. YUTIQ is three-year intravitreal micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The product was approved by U.S. Food and Drug Administration in October 2018.
Moreover, increasing prevalence of ocular dysfunction and disorder is expected to drive growth of the global ocular implant market. For instance, in January 2019, according to Glaucoma research foundation, there were over 3 million people in the U.S. that had been diagnosed with glaucoma. The National Eye Institute projects that this number will be increased by 58% and is expected to reach 4.2 million by 2030.
Key features of the study:
- This report provides an in-depth analysis of the global ocular implant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global ocular implant market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Staar Surgical, Johnson & Johnson Services, Inc., Bausch & Lomb Incorporated., Morcher GmbH, OSD Medical GmbH, Ophtec BV, and ZEISS International
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global ocular implant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ocular implant market
Detailed Segmentation:
- Global Ocular Implants Market, By Implant Type:
- Intraocular Lenses (IOL)
- Aspheric IOLs
- Toric IOLs
- Multifocal IOLs
- Anterior chamber IOLs
- Others
- Corneal Implants
- Glaucoma Implants
- Orbital Implants
- Ocular prosthesis
- Others
- Global Ocular Implants Market, By Application:
- Glaucoma Surgery
- Oculoplasty
- Drug Delivery
- Age-Related Macular Degeneration (AMD)
- Aesthetic purpose
- Others
- Global Ocular Implants Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Alcon (Novartis AG)*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Bausch & Lomb Incorporated
- Pfizer Inc
- MORCHER GmbH
- STAAR SURGICAL
- OSD Medical GmbH,
- Ophtec BV
- ZEISS International
“*” marked represents similar segmentation in other categories in the respective section.
